aap Implantate AG/€AAQ1
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About aap Implantate AG
aap Implantate AG is a medical technology company based in Berlin, Germany, specializing in the development, manufacturing, and marketing of trauma products for orthopedics. Its core offerings include the LOQTEQ® anatomical plating system and a range of cannulated screws designed for fracture treatment. The company is also advancing technologies such as antibacterial silver coating and magnesium-based implants to address unmet needs in trauma care. Founded in 1990, aap Implantate AG operates directly in Germany and through a network of distributors in approximately 25 countries, with a hybrid distribution strategy in the United States via its subsidiary, aap Implants Inc. In 2023, the company established a research and development and production headquarters in Suzhou New District, China, to conduct clinical trials on high-end silver ion anti-infection implants. This strategic expansion aims to enhance its presence in the Chinese market and leverage the region's favorable business environment.
Ticker
€AAQ1
Sector
Primary listing
XETRA
Employees
99
Headquarters
Website
AAQ1 Metrics
BasicAdvanced
€26m
-
-€0.19
0.37
-
Price and volume
Market cap
€26m
Beta
0.37
52-week high
€2.10
52-week low
€1.30
Average daily volume
6.7k
Financial strength
Current ratio
2.072
Quick ratio
0.851
Long term debt to equity
0.805
Total debt to equity
3.991
Interest coverage (TTM)
-41.75%
Profitability
EBITDA (TTM)
-1.778
Gross margin (TTM)
82.25%
Net profit margin (TTM)
-20.19%
Operating margin (TTM)
-21.20%
Effective tax rate (TTM)
0.54%
Revenue per employee (TTM)
€130,000
Management effectiveness
Return on assets (TTM)
-11.47%
Return on equity (TTM)
-26.99%
Valuation
Price to revenue (TTM)
2
Price to book
2.94
Price to tangible book (TTM)
2.95
Price to free cash flow (TTM)
-11.996
Free cash flow yield (TTM)
-8.34%
Free cash flow per share (TTM)
-0.155
Growth
Revenue change (TTM)
4.16%
Earnings per share change (TTM)
-46.99%
3-year revenue growth (CAGR)
3.18%
10-year revenue growth (CAGR)
-1.16%
3-year earnings per share growth (CAGR)
-24.23%
10-year earnings per share growth (CAGR)
-19.91%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs